Research Article
Identification of MAN1B1 as a Novel Marker for Bladder Cancer and Its Relationship with Immune Cell Infiltration
Table 4
Univariate and multivariate analysis of PFI in BLCA patients.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| T stage | 380 | | | | | T1 & T2 | 124 | Reference | | | | T3 | 196 | 1.848 (1.261–2.710) | 0.002 | 2.354 (1.159–4.780) | 0.018 | T4 | 60 | 3.268 (2.043–5.227) | <0.001 | 2.934 (1.255–6.863) | 0.013 |
| N stage | 370 | | | | | N0 | 239 | Reference | | | | N1 | 46 | 2.394 (1.548–3.702) | <0.001 | 1.612 (0.824–3.155) | 0.163 | N2 & N3 | 85 | 3.157 (2.212–4.505) | <0.001 | 2.340 (1.274–4.300) | 0.006 |
| M stage | 213 | | | | | M0 | 202 | Reference | | | | M1 | 11 | 6.455 (3.117–13.367) | <0.001 | 1.770 (0.642–4.882) | 0.270 |
| MAN1B1 | 414 | | | | | Low | 207 | Reference | | | | High | 207 | 1.393 (1.038–1.870) | 0.027 | 1.478 (0.893–2.446) | 0.128 |
| Age | 414 | | | | | <=70 | 234 | Reference | | | | >70 | 180 | 1.066 (0.792–1.435) | 0.673 | | |
| Gender | 414 | | | | | Female | 109 | Reference | | | | Male | 305 | 0.891 (0.642–1.235) | 0.488 | | |
|
|